Usually, I'd start an article like this pointing at the amazing RoR, if such were available from my previous recommendation for the stock. And while I can show ...
The article discusses Cardinal Health (NYSE:CAH) with a focus on the author's decision to sell shares in 2024 and a review of 2026 estimates. The core of the analysis includes a rating downgrade for the stock, suggesting a less optimistic outlook on its future performance. The…
Market Samachar is a news aggregator. This article was originally published by seekingalpha.com. Tap the button above to read the full story on their site.